Kopion Asset Management LLC reduced its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 22.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 236,787 shares of the financial services provider’s stock after selling 68,827 shares during the quarter. Trupanion accounts for about 8.0% of Kopion Asset Management LLC’s holdings, making the stock its biggest position. Kopion Asset Management LLC owned approximately 0.56% of Trupanion worth $11,413,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. GAMMA Investing LLC raised its position in Trupanion by 18.5% in the 4th quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after buying an additional 267 shares during the last quarter. JPMorgan Chase & Co. grew its position in Trupanion by 2.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock worth $1,189,000 after purchasing an additional 738 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Trupanion in the 3rd quarter valued at about $54,000. Barclays PLC boosted its stake in shares of Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after buying an additional 47,262 shares during the last quarter. Finally, DF Dent & Co. Inc. grew its holdings in shares of Trupanion by 27.8% in the third quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock valued at $15,443,000 after acquiring an additional 80,014 shares in the last quarter.
Trupanion Price Performance
Shares of Trupanion stock traded up $3.14 on Wednesday, hitting $46.79. 43,973 shares of the company traded hands, compared to its average volume of 589,852. The firm’s 50-day simple moving average is $51.15 and its 200 day simple moving average is $45.27. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market cap of $1.98 billion, a P/E ratio of -146.22 and a beta of 1.61.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on TRUP shares. Northland Securities boosted their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Piper Sandler lifted their price objective on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Finally, Stifel Nicolaus raised their target price on Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $45.33.
Read Our Latest Report on TRUP
Insider Activity
In other Trupanion news, SVP Emily Dreyer sold 3,100 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the transaction, the senior vice president now directly owns 24,708 shares in the company, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the completion of the sale, the chief financial officer now owns 9,867 shares of the company’s stock, valued at $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 28,597 shares of company stock valued at $1,522,082. Company insiders own 5.50% of the company’s stock.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Insider Trades May Not Tell You What You Think
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
- Best Stocks Under $10.00
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- How to Invest in the Best Canadian StocksĀ
- Can Integrated Healthcare Stocks Succeed in Public Markets?
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.